메뉴 건너뛰기




Volumn 147, Issue 1, 2014, Pages 20-24

Drug-induced liver injury: Morbidity, mortality, and Hy's law

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

EID: 84902970313     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2014.05.027     Document Type: Editorial
Times cited : (41)

References (16)
  • 1
    • 84903207339 scopus 로고    scopus 로고
    • Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury
    • M. Robles-Diaz, M.I. Lucena, and N. Kaplowitz et al. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury Gastroenterology 147 2014 109 118
    • (2014) Gastroenterology , vol.147 , pp. 109-118
    • Robles-Diaz, M.1    Lucena, M.I.2    Kaplowitz, N.3
  • 2
    • 33646024613 scopus 로고    scopus 로고
    • Hy's law: Predicting serious hepatotoxicity
    • R. Temple Hy's law: predicting serious hepatotoxicity Pharmacoepidemiol Drug Safe 15 2006 241 243
    • (2006) Pharmacoepidemiol Drug Safe , vol.15 , pp. 241-243
    • Temple, R.1
  • 3
    • 33646024905 scopus 로고    scopus 로고
    • How can 'Hy's law' help the clinician?
    • J.R. Senior How can 'Hy's law' help the clinician? Pharmacoepidemiol Drug Safe 15 2006 235 239
    • (2006) Pharmacoepidemiol Drug Safe , vol.15 , pp. 235-239
    • Senior, J.R.1
  • 4
    • 23044473682 scopus 로고    scopus 로고
    • Outcome and prognostic markers in severe drug-induced liver disease
    • E. Bjornsson, and R. Olsson Outcome and prognostic markers in severe drug-induced liver disease Hepatology 42 2005 481 489
    • (2005) Hepatology , vol.42 , pp. 481-489
    • Bjornsson, E.1    Olsson, R.2
  • 5
    • 18744376412 scopus 로고    scopus 로고
    • Drug-induced liver injury: An analysis of 461 incidences submitted to the Spanish registry over a 10-year period
    • R.L. Andrade, M.I. Lucena, and M.C. Fernandez et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period Gastroenterology 129 2005 512 521
    • (2005) Gastroenterology , vol.129 , pp. 512-521
    • Andrade, R.L.1    Lucena, M.I.2    Fernandez, M.C.3
  • 6
    • 57249086242 scopus 로고    scopus 로고
    • Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Drug Induced Liver Injury Network (DILIN)
    • N. Chalasani, R.J. Fontana, and H.L. Bonkovsky et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Drug Induced Liver Injury Network (DILIN) Gastroenterology 135 2008 1924 1934
    • (2008) Gastroenterology , vol.135 , pp. 1924-1934
    • Chalasani, N.1    Fontana, R.J.2    Bonkovsky, H.L.3
  • 7
    • 84901777524 scopus 로고    scopus 로고
    • Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset
    • R.J. Fontana, P.H. Hayashi, and J. Gu et al. Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset Gastroenterology 147 2014 96 108
    • (2014) Gastroenterology , vol.147 , pp. 96-108
    • Fontana, R.J.1    Hayashi, P.H.2    Gu, J.3
  • 8
    • 84938818093 scopus 로고    scopus 로고
    • Drug-induced livery injury: Premarketing clinical evaluation
    • Accessed April 15, 2014
    • US Food and Drug Administration. Drug-induced livery injury: premarketing clinical evaluation. In: Guidance for industry. 2009. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM174090.pdf. Accessed April 15, 2014.
    • (2009) Guidance for Industry
  • 11
    • 79951784125 scopus 로고    scopus 로고
    • Evaluation of drug-induced serious hepatotoxicity (eDISH) application of this data organization approach to phase iii clinical trials of rivaroxaban after total hip or knee replacement surgery
    • P.B. Watkins, M. Desai, and S.D. Berkowitz et al. Evaluation of drug-induced serious hepatotoxicity (eDISH) application of this data organization approach to phase iii clinical trials of rivaroxaban after total hip or knee replacement surgery Drug Safety 34 2011 243 252
    • (2011) Drug Safety , vol.34 , pp. 243-252
    • Watkins, P.B.1    Desai, M.2    Berkowitz, S.D.3
  • 12
    • 84886580385 scopus 로고    scopus 로고
    • Laboratory tests
    • E.R. Schiff, W.C. Maddrey, M.F. Sorrell, 11th ed. Wiley-Blackwell New York
    • H.F. Herlong, and M.C. Mitchell Laboratory tests E.R. Schiff, W.C. Maddrey, M.F. Sorrell, Schiff's diseases of the liver 11th ed. 2012 Wiley-Blackwell New York 17 43
    • (2012) Schiff's Diseases of the Liver , pp. 17-43
    • Herlong, H.F.1    Mitchell, M.C.2
  • 13
    • 84878325626 scopus 로고    scopus 로고
    • Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland
    • E.S. Björnsson, O.M. Bergmann, and H.K. Björnsson et al. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland Gastroenterology 144 2013 1419 1425
    • (2013) Gastroenterology , vol.144 , pp. 1419-1425
    • Björnsson, E.S.1    Bergmann, O.M.2    Björnsson, H.K.3
  • 15
    • 59349097386 scopus 로고    scopus 로고
    • The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice
    • E. Björnsson, and L. Davidsdottir The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice J Hepatology 50 2009 511 517
    • (2009) J Hepatology , vol.50 , pp. 511-517
    • Björnsson, E.1    Davidsdottir, L.2
  • 16
    • 33845666885 scopus 로고    scopus 로고
    • Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry
    • R.J. Andrade, M.I. Lucena, and N. Kaplowitz et al. Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry Hepatology 44 2006 1581 1588
    • (2006) Hepatology , vol.44 , pp. 1581-1588
    • Andrade, R.J.1    Lucena, M.I.2    Kaplowitz, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.